Literature DB >> 17968837

Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006.

Jeanne C Keruly1, Richard D Moore.   

Abstract

BACKGROUND: Human immunodeficiency virus (HIV) prevention initiatives to improve access to HIV services have increased over time. Despite this, >250,000 cases of HIV infection in the United States are undiagnosed, and many infected persons do not present for care until their HIV infection is advanced. Late presentation may increase the risk of HIV transmission and make HIV infection more difficult to treat effectively. With more effective HIV therapy, it was hoped that patients might present earlier in their disease course.
METHODS: To assess immune status and time of HIV diagnosis in patients who newly presented for care, we analyzed data for the period 1990-2006 from patients who were antiretroviral naive at presentation to the Johns Hopkins HIV Clinic in Baltimore, Maryland. We compared CD4(+) cell count and time from HIV diagnosis at presentation by demographic characteristics at enrollment.
RESULTS: The median presenting CD4(+) cell count decreased from 371 cells/mm(3) during 1990-1994 to 276 cells/mm(3) during 2003-2006 (P<.01) overall and decreased within individual demographic groups. There was also a decrease in the median time from HIV diagnosis to presentation for care (271 days in 1990-1994 to 196 days in 2003-2006; P<.01). Multivariate analysis revealed that, in addition to CD4(+) cell count at presentation, male sex was associated with lower CD4(+) cell counts (-93 cells/mm(3)), as was black race (-71 cells/mm(3)) and older age (-20 cells/mm(3) per 10 years).
CONCLUSIONS: There has been a decrease in time from diagnosis of HIV infection to presentation for care, coupled with an increase in the severity of immunocompromise at time of presentation, over the past 16 years in Maryland. New strategies to provide earlier HIV testing and referral into care are urgently needed.

Entities:  

Mesh:

Year:  2007        PMID: 17968837     DOI: 10.1086/522759

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  34 in total

1.  Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008.

Authors:  Shruti H Mehta; Gregory D Kirk; Jacquie Astemborski; Noya Galai; David D Celentano
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

2.  Barriers and facilitators to HIV testing and linkage to primary care: narratives of people with advanced HIV in the Southeast.

Authors:  Sandra I McCoy; William C Miller; Pia D M MacDonald; Christopher B Hurt; Peter A Leone; Joseph J Eron; Ronald P Strauss
Journal:  AIDS Care       Date:  2009-10

3.  Missed visits and mortality among patients establishing initial outpatient HIV treatment.

Authors:  Michael J Mugavero; Hui-Yi Lin; James H Willig; Andrew O Westfall; Kimberly B Ulett; Justin S Routman; Sarah Abroms; James L Raper; Michael S Saag; Jeroan J Allison
Journal:  Clin Infect Dis       Date:  2009-01-15       Impact factor: 9.079

4.  Hospitalization risk following initiation of highly active antiretroviral therapy.

Authors:  S A Berry; Y C Manabe; R D Moore; K A Gebo
Journal:  HIV Med       Date:  2009-12-08       Impact factor: 3.180

5.  Excess mortality after HIV seroconversion has greatly decreased in the past 10 years.

Authors:  Richard D Moore
Journal:  Evid Based Med       Date:  2009-02

6.  The therapeutic implications of timely linkage and early retention in HIV care.

Authors:  Kimberly B Ulett; James H Willig; Hui-Yi Lin; Justin S Routman; Sarah Abroms; Jeroan Allison; Ashlee Chatham; James L Raper; Michael S Saag; Michael J Mugavero
Journal:  AIDS Patient Care STDS       Date:  2009-01       Impact factor: 5.078

7.  Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia.

Authors:  Zewdie Mulissa; Degu Jerene; Bernt Lindtjørn
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

8.  Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort.

Authors:  Alan R Lifson; Elizabeth M Krantz; Lynn E Eberly; Matthew J Dolan; Vincent C Marconi; Amy C Weintrob; Nancy F Crum-Cianflone; Anuradha Ganesan; Patricia L Grambsch; Brian K Agan
Journal:  AIDS Res Ther       Date:  2011-01-18       Impact factor: 2.250

9.  Using the HIV surveillance system to monitor the National HIV/AIDS Strategy.

Authors:  Kristen Mahle Gray; Tian Tang; Luke Shouse; Jianmin Li; Jonathan Mermin; H Irene Hall
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

10.  Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study.

Authors:  Christine U Oramasionwu; Jonathan M Hunter; Jeff Skinner; Laurajo Ryan; Kenneth A Lawson; Carolyn M Brown; Brittany R Makos; Christopher R Frei
Journal:  BMC Infect Dis       Date:  2009-08-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.